Friday, May 10, 2024
HomePharma

Pharma

Pharma

Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable

Life Sciences Times - 0
Pharma

Anumana Receives U.S. FDA 510(k) Clearance for ECG-AI Algorithm to Detect Low Ejection Fraction

Life Sciences Times - 0
Pharma

SCHOTT TOPPAC® freeze Wins Pharma Innovation Award

Life Sciences Times - 0
Pharma

Tris Pharma Secures First ex-US Authorizations for Quillivant ER Oral Suspension and Quillivant ER Chewable Tablet for the Treatment of Attention Deficit Hyperactivity Disorder

Life Sciences Times - 0
Pharma

Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas

Life Sciences Times - 0
Pharma

Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica

Life Sciences Times - 0
Pharma

Critical agreement paves way for new model to accelerate access to important antibiotics for serious bacterial infections

Life Sciences Times - 0
Pharma

Merz Aesthetics® Expands Upon NEOCUTIS® Skincare Line with Launch of New ‘Neo Restore Post Treatment Nourishing Sheet Mask’

Life Sciences Times - 0
Pharma

Laurent Pharmaceuticals Receives Health Canada’s Approval to Initiate Phase 2/3 Clinical Trial in Long COVID

Life Sciences Times - 0
Pharma

U.S. FDA Approves Bristol Myers Squibb’s Reblozyl® (luspatercept-aamt) as First-Line Treatment of Anemia in Adults with Lower-Risk Myelodysplastic Syndromes (MDS) Who May Require Transfusions

Life Sciences Times - 0
Pharma

Tris Pharma Awarded Five-Year Grant of Up to $16.6M From the NIH’s National Institute on Drug Abuse to Advance Cebranopadol for the Treatment of...

Life Sciences Times - 0
Pharma

Artiva Biotherapeutics Announces FDA Clearance of IND for AlloNK® Cell Therapy Candidate in Combination with Rituximab in Lupus Nephritis

Life Sciences Times - 0
1...345...56Page 4 of 56

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Contact us: editorial@mishragroup.com

FOLLOW US

© Newspaper WordPress Theme by TagDiv